IMWG Conference Series - Copenhagen 2016: Is maintenance a standard of care?
Discussed is the value of Revlimid (lenalidomide) maintenance post-autologous stem cell transplant (as based on a recent French study).
IMWG Myeloma Experts debate the latest trends in treatment
June 9, 2016
Copenhagen, Denmark
Previous Post
IMWG Conference Series - Copenhagen 2016: How do you sequence new therapies?
Next Post
IMWG Conference Series - Copenhagen 2016: How do you use MRD testing?